Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial

被引:0
|
作者
Garon, Edward B.
Ardizzoni, Andrea
Barlesi, Fabrice
Cho, Byoung Chul
De Marchi, Pedro
Goto, Yasushi
Kowalski, Dariusz
Lu, Shun
Spigel, David R.
Thomas, Michael
Yang, James Chih-Hsin
Turri, Sabine
Zhou, Wen
Kreisl, Teri
Paz-Ares, Luis
机构
关键词
D O I
10.1158/1535-7163.TARG-21-LBA039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA039
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer: CANOPY-A Trial
    Spira, A.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B.
    de Marchi, P.
    Goto, Y.
    Kowalski, D.
    Lu, S.
    Paz-Ares, L.
    Spigel, D.
    Thomas, M.
    Turri, S.
    Rodrik-Outmezguine, V.
    Zhou, W.
    Kreisl, T.
    Yang, J.
    Garon, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [2] Canakinumab as adjuvant therapy in patients with completely resected non-small cell lung cancer: CANOPY-A trial.
    Spira, Alexander
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Kowalski, Dariusz
    Lu, Shun
    Paz-Ares, Luis
    Spigel, David R.
    Thomas, Michael
    Turri, Sabine
    Rodrik-Outmezguine, Vanessa
    Zhou, Wen
    Kreisl, Terri
    Yang, James Chih-Hsin
    Garon, Edward B.
    CANCER RESEARCH, 2021, 81 (13)
  • [3] Canakinumab as Adjuvant Therapy in Patients with Completely Resected Non-Small Cell Lung Cancer (NSCLC): CANOPY-A Trial
    Spira, A. I.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B. C.
    De Marchi, P.
    Goto, Y.
    Kowalski, D.
    Lu, S.
    Paz-Ares, L.
    Spigel, D. R.
    Thomas, M.
    Leung, M.
    Baum, J.
    Zhou, W.
    Portella, S.
    Yang, J. Chih-Hsin
    Garon, E. B.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S25 - S25
  • [4] CANOPY-A: Phase III study of canakinumab (CAN) as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC)
    Garon, E. B.
    Lu, S.
    Goto, Y.
    De Marchi, P. R.
    Paz-Ares, L.
    Spigel, D. R.
    Thomas, M.
    Yang, J. C-H.
    Ardizzoni, A.
    Barlesi, F.
    Khanna, S.
    Bossen, C.
    Carbini, M.
    Yovine, A.
    Cho, B. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1414 - S1415
  • [5] Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial
    Garon, Edward B.
    Lu, Shun
    Goto, Yasushi
    De Marchi, Pedro
    Paz-Ares, Luis
    Spigel, David R.
    Thomas, Michael
    Yang, James Chih-Hsin
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Orlov, Sergey
    Yoshioka, Hiroshige
    Mountzios, Giannis
    Khanna, Sadhvi
    Bossen, Claudia
    Carbini, Mariana
    Turri, Sabine
    Myers, Andrea
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (02) : 180 - 191
  • [6] CANOPY-A:A phase Ill study of canakinumab as adjuvant therapy in patients with surgically resected non -small cell lung cancer (NSCLC).
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Lu, Shun
    Paz-Ares, Luis G.
    Spigel, David R.
    Thomas, Michael
    Mookerjee, Bijoyesh
    Arratia, Pilar Cazorla
    Baum, Jason
    Lau, Yi-Yang Yvonne
    Zhu, Zewen
    Yang, James Chih-Hsin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] CANOPY-A: A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab as adjuvant therapy in patients (pts) with completely resected non-small cell lung cancer (NSCLC).
    Garon, Edward B.
    Ardizzoni, Andrea
    Barlesi, Fabrice
    Cho, Byoung Chul
    De Marchi, Pedro
    Goto, Yasushi
    Kowalski, Dariusz M.
    Lu, Shun
    Paz-Ares, Luis G.
    Spigel, David R.
    Spira, Alexander, I
    Thomas, Michael
    Leung, Mimi
    Baum, Jason
    Zhu, Zewen
    Oliveira Portella, Maria do Socorro
    Yang, James Chih-Hsin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Adjuvant chemotherapy in patients with completely resected non-small cell lung cancer
    Pirker, Robert
    TRANSLATIONAL LUNG CANCER RESEARCH, 2014, 3 (05) : 305 - 310
  • [9] CANOPY-A: a Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
    Spigel, D. R.
    Garon, E. B.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B. C.
    Marchi, P. D.
    Goto, Y.
    Lu, S.
    Paz-Ares, L.
    Thomas, M.
    Mookerjee, B.
    Leung, M.
    Baum, J.
    Zewen, Z.
    Yang, J. C-H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1135 - S1136
  • [10] CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients with Surgically Resected NSCLC
    Garon, E.
    Ardizzoni, A.
    Barlesi, F.
    Cho, B. C.
    De Marchi, P.
    Goto, Y.
    Lu, S.
    Paz-Ares, L.
    Spigel, D.
    Thomas, M.
    Mookerjee, B.
    Arratia, P.
    Baum, J.
    Zewen, Z.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S638 - S639